Literature DB >> 12684068

To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways.

Anthony K F Liou1, Robert S Clark, David C Henshall, Xiao-Ming Yin, Jun Chen.   

Abstract

After a severe episode of ischemia, traumatic brain injury (TBI) or epilepsy, it is typical to find necrotic cell death within the injury core. In addition, a substantial number of neurons in regions surrounding the injury core have been observed to die via the programmed cell death (PCD) pathways due to secondary effects derived from the various types of insults. Apart from the cell loss in the injury core, cell death in regions surrounding the injury core may also contribute to significant losses in neurological functions. In fact, it is the injured neurons in these regions around the injury core that treatments are targeting to preserve. In this review, we present our cumulated understanding of stress-activated signaling pathways and apoptotic pathways in the research areas of ischemic injury, TBI and epilepsy and that gathered from concerted research efforts in oncology and other diseases. However, it is obvious that our understanding of these pathways in the context of acute brain injury is at its infancy stage and merits further investigation. Hopefully, this added research effort will provide a more detailed knowledge from which better therapeutic strategies can be developed to treat these acute brain injuries.

Entities:  

Mesh:

Year:  2003        PMID: 12684068     DOI: 10.1016/s0301-0082(03)00005-4

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  85 in total

Review 1.  Neuroprotective effects of ischemic preconditioning in brain mitochondria following cerebral ischemia.

Authors:  Miguel A Pérez-Pinzón
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

2.  Light at the End of the "TUNEL"? Role of Ceramide in Seizure-induced Programmed Cell Death.

Authors:  Carl E. Stafstrom
Journal:  Epilepsy Curr       Date:  2003-09       Impact factor: 7.500

Review 3.  Neuronal survival in epilepsy: to die or not to die?

Authors:  Subramaniam Ganesh; Shweta Singh
Journal:  J Biosci       Date:  2005-12       Impact factor: 1.826

4.  Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823.

Authors:  Wei Liu; Qing-Long Guo; Qi-Dong You; Li Zhao; Hong-Yan Gu; Sheng-Tao Yuan
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 5.  Morphological characteristics of apoptosis and its significance in neurogenesis.

Authors:  S G Kalinichenko; N Yu Matveeva
Journal:  Neurosci Behav Physiol       Date:  2008-05

Review 6.  Epigenetic mechanisms in stroke and epilepsy.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Neuropsychopharmacology       Date:  2012-08-15       Impact factor: 7.853

Review 7.  Ischemic tolerance as an active and intrinsic neuroprotective mechanism.

Authors:  R Anne Stetler; Feng Zhang; Collin Liu; Jun Chen
Journal:  Handb Clin Neurol       Date:  2009

Review 8.  The emerging field of epigenetics in neurodegeneration and neuroprotection.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

9.  Dynamin-Related Protein 1 Promotes Mitochondrial Fission and Contributes to The Hippocampal Neuronal Cell Death Following Experimental Status Epilepticus.

Authors:  Shang-Der Chen; Yen-Yi Zhen; Jui-Wei Lin; Tsu-Kung Lin; Chin-Wei Huang; Chia-Wei Liou; Samuel H H Chan; Yao-Chung Chuang
Journal:  CNS Neurosci Ther       Date:  2016-08-31       Impact factor: 5.243

10.  Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1- and p53-dependent prodeath pathways after ischemic injury.

Authors:  Rehana K Leak; Lili Zhang; Yumin Luo; Peiying Li; Haiping Zhao; Xiangrong Liu; Feng Ling; Jianping Jia; Jun Chen; Xunming Ji
Journal:  Stroke       Date:  2013-02-21       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.